LEADER 01376nam  2200385Ia 450 
001 9910698801803321
005 20090608160313.0
035   $a(CKB)5470000002397853
035   $a(OCoLC)375052652
035   $a(EXLCZ)995470000002397853
100   $a20090608d1998      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eguidance for human somatic cell therapy and gene therapy
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[1998]
215   $aii, 27 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on June 8, 2009).
300   $a"March 1998".
517   $aGuidance for industry 
606   $aSomatic cells
606   $aCellular therapy$xGovernment policy$zUnited States
606   $aGene therapy$xGovernment policy$zUnited States
615  0$aSomatic cells.
615  0$aCellular therapy$xGovernment policy
615  0$aGene therapy$xGovernment policy
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698801803321
996   $aGuidance for industry$93434577
997   $aUNINA